|
|
Volumn 1, Issue 4, 2004, Pages 296-301
|
|
Use of nonviral vectors for cystic fibrosis gene therapy.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CFTR PROTEIN, HUMAN;
TRANSMEMBRANE CONDUCTANCE REGULATOR;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CYSTIC FIBROSIS;
FEMALE;
GENE THERAPY;
GENE VECTOR;
GENETICS;
HUMAN;
MALE;
METHODOLOGY;
PROGNOSIS;
REVIEW;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
TREATMENT OUTCOME;
UNITED KINGDOM;
CLINICAL TRIALS;
CYSTIC FIBROSIS;
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;
FEMALE;
GENE THERAPY;
GENETIC VECTORS;
GREAT BRITAIN;
HUMANS;
MALE;
PROGNOSIS;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
TREATMENT OUTCOME;
|
|
EID: 26944451362
PISSN: 15463222
EISSN: None
Source Type: Journal
DOI: 10.1513/pats.200404-031MS Document Type: Review |
|
Times cited : (16)
|
|
References (42)
|
